Neuroimaging through the course of Alzheimer's disease.
暂无分享,去创建一个
[1] Jeffrey A. James,et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.
[2] M. Borga,et al. Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: The Göteborg MCI study , 2008, Journal of the Neurological Sciences.
[3] Mark S. Cohen,et al. Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.
[4] Stanley I. Rapoport,et al. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[5] R. K. Hutson,et al. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment , 2008, Alzheimer's & Dementia.
[6] Felice Sun,et al. Brain imaging evidence of preclinical Alzheimer's disease in normal aging , 2006, Annals of neurology.
[7] J. Morris,et al. Mild cognitive impairment and preclinical Alzheimer's disease. , 2005, Geriatrics.
[8] Zhijun Zhang,et al. Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: A combined structural and resting-state functional MRI study , 2008, Neuroscience Letters.
[9] Paul M. Thompson,et al. Hippocampal shape analysis in Alzheimer’s disease: A population-based study , 2007, NeuroImage.
[10] Harald Hampel,et al. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. , 2007, Cerebral cortex.
[11] Ruth O'Hara,et al. Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. , 2002, Journal of psychiatric research.
[12] James F. Calvert,et al. Factors associated with resistance to dementia despite high Alzheimer disease pathology , 2009, Neurology.
[13] W. M. van der Flier,et al. Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET , 2009, Journal of Nuclear Medicine.
[14] Vince D. Calhoun,et al. Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.
[15] D. Bennett,et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study , 2006, Neurobiology of Aging.
[16] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[17] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[18] B. Reisberg,et al. Mild cognitive impairment in the elderly , 1991, Neurology.
[19] Takashi Yoshiura,et al. Diffusion tensor in posterior cingulate gyrus: correlation with cognitive decline in Alzheimer's disease , 2002, Neuroreport.
[20] Gene E. Alexander,et al. Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.
[21] G. Small,et al. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment , 2008, The journal of nutrition, health & aging.
[22] Norbert Schuff,et al. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry , 2008, NeuroImage.
[23] A. Smith,et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.
[24] Eini Niskanen,et al. Whole brain atrophy rate predicts progression from MCI to Alzheimer’s disease , 2010, Neurobiology of Aging.
[25] B. L. Beattie,et al. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[26] Takashi Inoue,et al. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging , 2002, Neuroscience Letters.
[27] Michael I. Miller,et al. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly , 2005, NeuroImage.
[28] R. Buckner,et al. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD , 2005, Neurology.
[29] J. Baron,et al. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment , 2002, Neuroreport.
[30] Christian Sorg,et al. A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[31] P. Thompson,et al. PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.
[32] D. Anchisi,et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD , 2006, Neurobiology of Aging.
[33] C. Jack,et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.
[34] W. Markesbery,et al. Delayed recall, hippocampal volume and Alzheimer neuropathology , 2004, Neurology.
[35] A. Saykin,et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI , 2006, Neurology.
[36] S. Rose,et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[37] Bruce G. Link,et al. Relationship between lifetime occupation and parietal flow , 1995, Neurology.
[38] C. Jack,et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.
[39] G. Alexander,et al. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease , 1992, Annals of neurology.
[40] S. Petersen,et al. The maturing architecture of the brain's default network , 2008, Proceedings of the National Academy of Sciences.
[41] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[42] M. Essig,et al. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. , 2003, The American journal of psychiatry.
[43] Abraham Z. Snyder,et al. A default mode of brain function: A brief history of an evolving idea , 2007, NeuroImage.
[44] H. Braak,et al. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.
[45] M. Filippi,et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.
[46] F. Schmitt,et al. Brain structural alterations before mild cognitive impairment , 2007, Neurology.
[47] J. Kaye,et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease , 2004, Neurology.
[48] H. Braak,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[49] R. Petersen,et al. Alzheimer's disease and mild cognitive impairment. , 2007, Neurologic clinics.
[50] K. Herholz,et al. Impaired metabolic activation in Alzheimer's disease: A pet study during continuous visual recognition , 1991, Neuropsychologia.
[51] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[52] A. Auchus,et al. Diffusion Tensor Imaging of Normal-Appearing White Matter in Mild Cognitive Impairment and Early Alzheimer Disease: Preliminary Evidence of Axonal Degeneration in the Temporal Lobe , 2007, American Journal of Neuroradiology.
[53] James T. Becker,et al. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B , 2008, Journal of Neuroscience Methods.
[54] Keith A. Johnson,et al. Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.
[55] M. Albert,et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[56] B. Winblad,et al. Mild cognitive impairment--an early stage of Alzheimer's disease? , 1998, Journal of neural transmission. Supplementum.
[57] J. Price,et al. Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.
[58] J R Moeller,et al. Activate your online subscription , 2000, Neurology.
[59] Christos Davatzikos,et al. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.
[60] G. Small,et al. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[61] Cheuk Y. Tang,et al. Patterns of cortical activity and memory performance in Alzheimer’s disease , 2001, Biological Psychiatry.
[62] J. Kaye,et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia , 1997, Neurology.
[63] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[64] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] Gregory G. Brown,et al. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease , 2005, Neurology.
[66] A. Saykin,et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation , 1999, Journal of the International Neuropsychological Society.
[67] J. Voyvodic,et al. Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. , 2000, AJNR. American journal of neuroradiology.
[68] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[69] D. Knopman,et al. Dissociation of regional activation in mild AD during visual encoding , 2001, Neurology.
[70] M. Leon,et al. Hippocampal atrophy in normal aging. An association with recent memory impairment. , 1993, Archives of neurology.
[71] Michael Erb,et al. Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[72] Michael E Phelps,et al. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. , 2009, Archives of general psychiatry.
[73] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[74] Charles D. Smith,et al. Neuronal fiber pathway abnormalities in autism: An initial MRI diffusion tensor tracking study of hippocampo-fusiform and amygdalo-fusiform pathways , 2008, Journal of the International Neuropsychological Society.
[75] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[76] H. Braak,et al. Relationship between Clinical and Radiological Diagnostic Criteria for Alzheimer’s Disease and the Extent of Neuropathology as Reflected by ‘Stages’: A Prospective Study , 1999, Dementia and Geriatric Cognitive Disorders.
[77] S. Santi,et al. Hippocampal hypometabolism predicts cognitive decline from normal aging , 2008, Neurobiology of Aging.
[78] B. Reisberg,et al. Global Deterioration Scale (GDS). , 1988, Psychopharmacology bulletin.
[79] M. Albert,et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD , 2005, Neurology.
[80] H. Hanyu,et al. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.
[81] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[82] P Pietrini,et al. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. , 1997, The American journal of psychiatry.
[83] R. Sperling,et al. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[84] John J Sidtis,et al. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.
[85] P. Pietrini,et al. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. , 2001, Brain : a journal of neurology.
[86] G. Alexander,et al. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. , 1999, The American journal of psychiatry.
[87] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[88] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[89] P Pietrini,et al. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. , 1998, The American journal of psychiatry.
[90] G. Zubicaray,et al. Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[91] S. Rombouts,et al. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study , 2005, Human brain mapping.
[92] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[93] N. Schuff,et al. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease , 2006, Neuroscience Letters.
[94] P Pietrini,et al. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[95] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[96] F. Schmitt,et al. Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly , 2007, Neurobiology of Aging.
[97] I. Siegert,et al. Presenilin-1–associated abnormalities in regional cerebral perfusion , 2001, Neurology.
[98] P. Celsis,et al. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? , 2000, Annals of medicine.
[99] John C Morris,et al. Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.
[100] Kiralee M. Hayashi,et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.
[101] D. Collins,et al. Amnestic MCI future clinical status prediction using baseline MRI features , 2010, Neurobiology of Aging.
[102] M. P. van den Heuvel,et al. Microstructural Organization of the Cingulum Tract and the Level of Default Mode Functional Connectivity , 2008, The Journal of Neuroscience.
[103] D. Loewenstein,et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease , 2008, Neurology.
[104] J. Baron,et al. Mild cognitive impairment , 2003, Neurology.
[105] C. Jack,et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial , 2002, Journal of Molecular Neuroscience.
[106] G. Chételat,et al. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry , 2008, Neuropsychologia.
[107] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[108] M. Viitanen,et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment , 2007, Neurology.
[109] William E. Klunk,et al. Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.
[110] Sterling C. Johnson,et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study , 2006, BMC medicine.
[111] Frederik Barkhof,et al. Model‐free group analysis shows altered BOLD FMRI networks in dementia , 2009, Human brain mapping.
[112] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[113] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[114] A. Smith,et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography , 1992, The Lancet.
[115] Y. Yuan,et al. Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis , 2008, American Journal of Neuroradiology.
[116] George Bartzokis,et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.
[117] Kiralee M. Hayashi,et al. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. , 2007, Archives of neurology.
[118] M. Albert,et al. Medial temporal lobe function and structure in mild cognitive impairment , 2004, Annals of neurology.
[119] Lars-Olof Wahlund,et al. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment , 2002, BMC neurology.
[120] Nick C Fox,et al. Amnestic Mild Cognitive Impairment: Structural MR Imaging Findings Predictive of Conversion to Alzheimer Disease , 2008, American Journal of Neuroradiology.
[121] A. Fleisher,et al. Identification of Alzheimer disease risk by functional magnetic resonance imaging. , 2005, Archives of neurology.
[122] Matthias J. Müller,et al. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment , 2005, Neurobiology of Aging.
[123] John W. Gilbert,et al. Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.
[124] H. Möller,et al. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. , 2006, Brain : a journal of neurology.
[125] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[126] R. Edelman,et al. Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.
[127] Anders H. Andersen,et al. White matter diffusion alterations in normal women at risk of Alzheimer's disease , 2010, Neurobiology of Aging.
[128] C. Rowe,et al. Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease , 2008, Neuropsychologia.
[129] Michael Weiner,et al. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects , 2008, NeuroImage.
[130] Ronald C Petersen,et al. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. , 2003, Mayo Clinic proceedings.
[131] M. Gearing,et al. The CERAD experience, part VIII , 1995, Neurology.
[132] J. Baron,et al. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment , 2005, Neurocase.
[133] G. Frisoni,et al. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study , 2008, Neurobiology of Aging.
[134] Andrew J. Saykin,et al. Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.
[135] Rachel L. Mistur,et al. Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal , 2010, Neurobiology of Aging.
[136] S. Leurgans,et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.
[137] M. Witter,et al. Functional MR imaging in Alzheimer's disease during memory encoding. , 2000, AJNR. American journal of neuroradiology.
[138] G. Frisoni,et al. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment , 2007, Journal of Neurology.
[139] J. Morris,et al. Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.
[140] Hiroshi Fukuda,et al. Voxel-based morphometry of human brain with age and cerebrovascular risk factors , 2004, Neurobiology of Aging.
[141] Yaakov Stern,et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. , 2003, Archives of neurology.
[142] N. Foster,et al. Alzheimer's disease , 1983, Neurology.
[143] H. Engler,et al. PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.
[144] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[145] Thanh-Thu T. Tran,et al. Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. , 2007, Radiology.
[146] Lei Wang,et al. Correlations Between Antemortem Hippocampal Volume and Postmortem Neuropathology in AD Subjects , 2004, Alzheimer disease and associated disorders.
[147] G. Frisoni,et al. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[148] C. Oppenheim,et al. Diffusion tensor imaging in early Alzheimer's disease , 2006, Psychiatry Research: Neuroimaging.
[149] Maximilian Reiser,et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.
[150] S. Rose,et al. Gray and white matter changes in Alzheimer's disease: A diffusion tensor imaging study , 2008, Journal of magnetic resonance imaging : JMRI.
[151] Andrew J. Saykin,et al. Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele , 2006 .
[152] S H Ferris,et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.
[153] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[154] A. Smith,et al. Imaging the progression of Alzheimer pathology through the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[155] Matthias J. Müller,et al. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus , 2006, Psychiatry Research: Neuroimaging.
[156] Jie Xu,et al. White matter damage of patients with Alzheimer’s disease correlated with the decreased cognitive function , 2006, Surgical and Radiologic Anatomy.
[157] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[158] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[159] A. Drzezga,et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[160] C. Cotman,et al. Evolution in the Conceptualization of Dementia and Alzheimer’s Disease: Greco-Roman Period to the 1960s , 1998, Neurobiology of Aging.
[161] N. Schuff,et al. Headache and cerebral venous air embolism , 2007, Neurology.
[162] G. Frisoni,et al. A voxel based morphometry study on mild cognitive impairment , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[163] J. Petrella,et al. Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment , 2007, PloS one.
[164] R. Sperling,et al. Functional MRI Studies of Associative Encoding in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.
[165] W. Markesbery,et al. Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease , 2008, Neurological research.
[166] C. DeCarli,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.
[167] A. Drzezga,et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[168] S A Small,et al. Evaluating the function of hippocampal subregions with high‐resolution MRI in Alzheimer's disease and aging , 2000, Microscopy research and technique.
[169] R. Mayeux,et al. Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.
[170] Charles D. Smith,et al. Women at risk for AD show increased parietal activation during a fluency task , 2002, Neurology.
[171] Nick C. Fox,et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.
[172] Maija Pihlajamäki,et al. Increased fMRI responses during encoding in mild cognitive impairment , 2007, Neurobiology of Aging.
[173] S. Schoenberg,et al. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. , 2007, Radiology.
[174] Kiralee M. Hayashi,et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. , 2006, Archives of neurology.
[175] Elisabet Englund,et al. Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[176] R. Sperling,et al. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease , 2007, Neurology.